We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Co-Diagnostics Inc (CODX) USD0.001

Sell:$1.11 Buy:$1.16 Change: $0.01 (0.89%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
Change: $0.01 (0.89%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
Change: $0.01 (0.89%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and selling reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, including molecular tools for the detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. It also uses its technology to design specific tests for its Co-Dx PCR Home platform and to locate genetic markers for use in applications other than infectious disease. It also sells diagnostic equipment from other manufacturers as self-contained lab systems. The Company is also developing a portable polymerase chain reaction (PCR) device and test cups that are designed to bring PCR to patients in point-of-care and even at-home settings. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

Contact details

4049 S Highland Dr
United States
+1 (801) 2789769

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$34.56 million
Shares in issue:
30.58 million
Health Care Equipment
United States
US dollar

Key personnel

  • Dwight Egan
    Chairman of the Board, President, Chief Executive Officer
  • Brian Brown
    Chief Financial Officer, Company Secretary
  • Mark Poritz
    Chief Scientific Officer
  • Ivory Chang
    Chief Regulatory Affairs Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.